RA Capital Healthcare Fund LP's Net Worth
$0
Who is RA Capital Healthcare Fund LP?
RA Capital Healthcare Fund LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., Dicerna Pharmaceuticals Inc, Eidos Therapeutics, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., DICE Therapeutics, Inc., SANGAMO BIOSCIENCES INC, Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., RxSight, Inc., Phathom Pharmaceuticals, Inc., TG THERAPEUTICS, INC., Eiger BioPharmaceuticals, Inc., Eliem Therapeutics, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Forma Therapeutics Holdings, Inc.,, Therapeutics Acquisition Corp., G1 Therapeutics, Inc., ARVINAS INC., Synthorx, Inc., CURIS INC, Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Aclaris Therapeutics, Inc., Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, Satsuma Pharmaceuticals, Inc., Akouos, Inc., Wave Life Sciences Ltd., Werewolf Therapeutics, Inc., IMARA Inc., Ra Pharmaceuticals, Inc., Nkarta, Inc., Fulcrum Therapeutics, Inc., scPharmaceuticals Inc., ACHILLION PHARMACEUTICALS INC, ARS Pharmaceuticals, Inc., PepGen Inc., Black Diamond Therapeutics, Inc., DERMA SCIENCES, INC., SEQUENOM INC, BIOSPECIFICS TECHNOLOGIES CORP, Acrivon Therapeutics, Inc., ARADIGM CORP, LIPID SCIENCES INC/, LENZ Therapeutics, Inc., Boundless Bio, Inc., Cidara Therapeutics, Inc., and Artiva Biotherapeutics, Inc..
SEC CIK
RA Capital Healthcare Fund LP's CIK is 0001315082
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $1.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -63.50% | -3.53M |
$1.08 | -$3,807,101.52 | 2.03M |
Aug 9
| |||
Form 4
| +52.94% | 1.78M |
$9.00 | $16,000,002.00 | 5.14M |
Aug 18
| |||
Form 4
| +0.03% | 1.91K |
$7.74 | $14,330.32 | 7.55M |
Aug 3 - Aug 4
| |||
Form 4
| +0.62% | 23.22K |
$7.78 | $180,674.69 | 3.77M |
Jul 26 - Jul 27
| |||
Form 4
| +0.01% | 302 |
$7.99 | $2,412.98 | 3.75M |
Jun 21
| |||
Form 4
| +2.22% | 81.42K |
$7.95 | $647,401.86 | 3.75M |
Jun 13 - Jun 14
| |||
Form 4
|
∞
| 3.67M |
$15.00 |
—
| 3.67M |
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.19% | -238.54K |
$29.47 | -$7,029,652.62 | 4.36M |
Dec 2 - Dec 3
| |||
Form 4
| -2.50% | -131.58K |
$22.06 | -$2,902,517.12 | 5.14M |
Jun 30 - Jul 2
| |||
Form 4
| -2.77% | -150.32K |
$23.05 | -$3,465,614.60 | 5.27M |
Jun 25 - Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vaxcyte, Inc. (PCVX) Snapshot price: $111.58
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.05% | -266.26K |
$50.78 | -$13,521,592.46 | 5M |
Oct 7 - Oct 8
| |||
Form 4
| -3.94% | -221.33K |
$49.81 | -$11,245,562.88 | 5.39M |
Sep 29 - Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +108.93% | 2.65M |
—
|
—
| 5.07M |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
∞
| 2.43M |
$15.00 |
—
| 2.43M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Eidos Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.16M |
$17.00 |
—
| 2.16M |
Jun 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |